原发性硬化性胆管炎MRI/MRCP报告标准:国际PSC研究组MR工作组指南
国际原发性硬化性胆管炎研究组MR工作组发布共识,为PSC的MRI/MRCP检查定义术语和报告标准,涵盖胆管狭窄严重度与长度、胆管壁增厚与强化、肝实质信号改变及胆管癌监测,并规范随访报告重要变化,以标准化诊断、病情评估和并发症检测。
要点
- 采用统一术语描述胆管狭窄的严重度、长度及胆管壁增厚与强化。
- 规范肝实质信号强度改变的评估与报告。
- 标准化PSC相关胆管癌的MRI/MRCP监测报告标准。
关键影像表现/征象
- PSC表现为胆管狭窄、进行性肝实质纤维化及肝胆恶性肿瘤(主要为胆管癌)风险增加。
- 共识定义了胆管狭窄的严重度和长度、胆管壁增厚和强化、肝实质信号强度改变的术语。
- 共识总结了PSC中发生胆管癌的标准化报告标准。
诊断标准与关键数值
- 共识提供胆管狭窄严重度和长度的定义与术语,但原文未给出具体数值阈值或分级标准。
- 共识提供胆管壁增厚和强化的定义与术语,但原文未给出具体数值阈值。
- 共识提供肝实质信号强度改变的定义与术语,但原文未给出具体数值阈值。
- 共识提供PSC中胆管癌的标准化报告标准,但原文未给出敏感度、特异度或AUC数值。
临床应用与阅片要点
- 日常阅片应按共识术语报告胆管狭窄的严重度和长度。
- 应评估并报告胆管壁增厚与强化程度。
- 应关注肝实质信号强度改变并规范描述。
- 随访检查中应识别并按共识报告重要变化,警惕胆管癌发生。
局限性
- 原文未报告共识制定的证据分级方法。
- 原文未报告样本量、中心数或验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder affecting the bile ducts and is characterized by biliary strictures, progressive liver parenchymal fibrosis, and an increased risk of hepatobiliary malignancies primarily cholangiocarcinoma (CCA). PSC may lead to portal hypertension, liver decompensation, and liver failure with the need for liver transplantation. Magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) are considered the imaging standard for diagnosis and follow-up in patients with PSC. Currently, there are no universally accepted reporting standards and definitions for MRI/MRCP features. Controversies exist about the definition of a high-grade stricture and there is no widely agreed approach to their management. The members of the MRI working group of the International Primary Sclerosing Cholangitis Study Group (IPSCSG) sought to define terminologies and reporting standards for describing MRI/MRCP features that would be applied to diagnosis and surveillance of disease progression, and potentially for evaluating treatment response in clinical trials. In this extensive review, the technique of MRI/MRCP and assessment of image quality for the evaluation of PSC is briefly described. The definitions and terminologies for severity and length of strictures, duct wall thickening and hyperenhancement, and liver parenchyma signal intensity changes are outlined. As CCA is an important complication of PSC, standardized reporting criteria for CCA developing in PSC are summarized. Finally, the guidelines for reporting important changes in follow-up MRI/MRCP studies are provided. KEY POINTS: • Primary sclerosing cholangitis is a chronic inflammatory disorder affecting the bile ducts, causing biliary strictures and liver fibrosis and an increased risk of cholangiocarcinoma. • This consensus document provides definitions and suggested reporting standards for MRI and MRCP features of primary sclerosing cholangitis, which will allow for a standardized approach to diagnosis, assessment of disease severity, follow-up, and detection of complications. • Standardized definitions and reporting of MRI/MRCP features of PSC will facilitate comparison between studies, promote longitudinal assessment during management, reduce inter-reader variability, and enhance the quality of care and communication between health care providers.
引用
- Venkatesh SK, Welle CL, Miller FH, et al. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. 2021. PMID: 34363134. doi:10.1007/s00330-021-08147-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。